FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:MAST2-SERBP1

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: MAST2-SERBP1
FusionPDB ID: 51838
FusionGDB2.0 ID: 51838
HgeneTgene
Gene symbol

MAST2

SERBP1

Gene ID

23139

26135

Gene namemicrotubule associated serine/threonine kinase 2SERPINE1 mRNA binding protein 1
SynonymsMAST205|MTSSKCGI-55|CHD3IP|HABP4L|PAI-RBP1|PAIRBP1
Cytomap

1p34.1

1p31.3

Type of geneprotein-codingprotein-coding
Descriptionmicrotubule-associated serine/threonine-protein kinase 2microtubule associated testis specific serine/threonine protein kinaseplasminogen activator inhibitor 1 RNA-binding proteinPAI-1 mRNA binding proteinPAI1 RNA-binding protein 1chromodomain helicase DNA binding protein 3 interacting protein
Modification date2020031320200313
UniProtAcc

Q6P0Q8

Main function of 5'-partner protein: FUNCTION: Appears to link the dystrophin/utrophin network with microtubule filaments via the syntrophins. Phosphorylation of DMD or UTRN may modulate their affinities for associated proteins. Functions in a multi-protein complex in spermatid maturation. Regulates lipopolysaccharide-induced IL-12 synthesis in macrophages by forming a complex with TRAF6, resulting in the inhibition of TRAF6 NF-kappa-B activation (By similarity). {ECO:0000250}.
.
Ensembl transtripts involved in fusion geneENST idsENST00000361297, ENST00000372009, 
ENST00000477968, 
ENST00000484880, 
ENST00000361219, ENST00000370990, 
ENST00000370994, ENST00000370995, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score25 X 15 X 13=48758 X 7 X 3=168
# samples 288
** MAII scorelog2(28/4875*10)=-4.12190348657937
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(8/168*10)=-1.0703893278914
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: MAST2 [Title/Abstract] AND SERBP1 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: MAST2 [Title/Abstract] AND SERBP1 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)MAST2(46425149)-SERBP1(67891968), # samples:1
Anticipated loss of major functional domain due to fusion event.MAST2-SERBP1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
MAST2-SERBP1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
TgeneSERBP1

GO:0030578

PML body organization

28695742



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr1:46425149/chr1:67891968)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across MAST2 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across SERBP1 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000372009MAST2chr146425149+ENST00000370994SERBP1chr167891968-71238752831725480
ENST00000372009MAST2chr146425149+ENST00000370995SERBP1chr167891968-39588752831788501
ENST00000372009MAST2chr146425149+ENST00000361219SERBP1chr167891968-25668752831743486
ENST00000372009MAST2chr146425149+ENST00000370990SERBP1chr167891968-21118752831770495
ENST00000361297MAST2chr146425149+ENST00000370994SERBP1chr167891968-71238752831725480
ENST00000361297MAST2chr146425149+ENST00000370995SERBP1chr167891968-39588752831788501
ENST00000361297MAST2chr146425149+ENST00000361219SERBP1chr167891968-25668752831743486
ENST00000361297MAST2chr146425149+ENST00000370990SERBP1chr167891968-21118752831770495

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000372009ENST00000370994MAST2chr146425149+SERBP1chr167891968-0.0037091380.9962909
ENST00000372009ENST00000370995MAST2chr146425149+SERBP1chr167891968-0.0024900390.99750996
ENST00000372009ENST00000361219MAST2chr146425149+SERBP1chr167891968-0.0146502050.9853498
ENST00000372009ENST00000370990MAST2chr146425149+SERBP1chr167891968-0.0216572820.9783427
ENST00000361297ENST00000370994MAST2chr146425149+SERBP1chr167891968-0.0037091380.9962909
ENST00000361297ENST00000370995MAST2chr146425149+SERBP1chr167891968-0.0024900390.99750996
ENST00000361297ENST00000361219MAST2chr146425149+SERBP1chr167891968-0.0146502050.9853498
ENST00000361297ENST00000370990MAST2chr146425149+SERBP1chr167891968-0.0216572820.9783427

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for MAST2-SERBP1

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
MAST2chr146425149SERBP1chr167891968875197TLPRPHSPLHGHTGIRRVGRRPDQQL

Top

Potential FusionNeoAntigen Information of MAST2-SERBP1 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
MAST2-SERBP1_46425149_67891968.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
MAST2-SERBP1chr146425149chr167891968875HLA-A31:01HTGIRRVGR0.96190.64441120
MAST2-SERBP1chr146425149chr167891968875HLA-C06:03HGHTGIRRV0.70880.9945918
MAST2-SERBP1chr146425149chr167891968875HLA-B39:10SPLHGHTGI0.34950.6385615
MAST2-SERBP1chr146425149chr167891968875HLA-C01:17HSPLHGHTGI0.83660.8902515
MAST2-SERBP1chr146425149chr167891968875HLA-C06:02HGHTGIRRV0.70930.9946918
MAST2-SERBP1chr146425149chr167891968875HLA-C06:17HGHTGIRRV0.70930.9946918
MAST2-SERBP1chr146425149chr167891968875HLA-C06:08HGHTGIRRV0.54270.9925918
MAST2-SERBP1chr146425149chr167891968875HLA-B67:01SPLHGHTGI0.47790.6174615
MAST2-SERBP1chr146425149chr167891968875HLA-C01:02HSPLHGHTGI0.84950.8991515

Top

Potential FusionNeoAntigen Information of MAST2-SERBP1 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
MAST2-SERBP1_46425149_67891968.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
MAST2-SERBP1chr146425149chr167891968875DRB1-0801GHTGIRRVGRRPDQQ1025
MAST2-SERBP1chr146425149chr167891968875DRB1-0801HTGIRRVGRRPDQQL1126
MAST2-SERBP1chr146425149chr167891968875DRB1-0805GHTGIRRVGRRPDQQ1025
MAST2-SERBP1chr146425149chr167891968875DRB1-0805HTGIRRVGRRPDQQL1126
MAST2-SERBP1chr146425149chr167891968875DRB1-0806GHTGIRRVGRRPDQQ1025
MAST2-SERBP1chr146425149chr167891968875DRB1-0806HTGIRRVGRRPDQQL1126
MAST2-SERBP1chr146425149chr167891968875DRB1-0806HGHTGIRRVGRRPDQ924
MAST2-SERBP1chr146425149chr167891968875DRB1-0810GHTGIRRVGRRPDQQ1025
MAST2-SERBP1chr146425149chr167891968875DRB1-0810HTGIRRVGRRPDQQL1126
MAST2-SERBP1chr146425149chr167891968875DRB1-0810HGHTGIRRVGRRPDQ924
MAST2-SERBP1chr146425149chr167891968875DRB1-0812GHTGIRRVGRRPDQQ1025
MAST2-SERBP1chr146425149chr167891968875DRB1-0812HTGIRRVGRRPDQQL1126
MAST2-SERBP1chr146425149chr167891968875DRB1-0812HGHTGIRRVGRRPDQ924
MAST2-SERBP1chr146425149chr167891968875DRB1-0816GHTGIRRVGRRPDQQ1025
MAST2-SERBP1chr146425149chr167891968875DRB1-0816HTGIRRVGRRPDQQL1126
MAST2-SERBP1chr146425149chr167891968875DRB1-0818GHTGIRRVGRRPDQQ1025
MAST2-SERBP1chr146425149chr167891968875DRB1-0822GHTGIRRVGRRPDQQ1025
MAST2-SERBP1chr146425149chr167891968875DRB1-0822HTGIRRVGRRPDQQL1126
MAST2-SERBP1chr146425149chr167891968875DRB1-0822HGHTGIRRVGRRPDQ924
MAST2-SERBP1chr146425149chr167891968875DRB1-0826GHTGIRRVGRRPDQQ1025
MAST2-SERBP1chr146425149chr167891968875DRB1-0826HTGIRRVGRRPDQQL1126
MAST2-SERBP1chr146425149chr167891968875DRB1-0829GHTGIRRVGRRPDQQ1025
MAST2-SERBP1chr146425149chr167891968875DRB1-0829HTGIRRVGRRPDQQL1126
MAST2-SERBP1chr146425149chr167891968875DRB1-0837GHTGIRRVGRRPDQQ1025
MAST2-SERBP1chr146425149chr167891968875DRB1-0839GHTGIRRVGRRPDQQ1025
MAST2-SERBP1chr146425149chr167891968875DRB1-0839HTGIRRVGRRPDQQL1126
MAST2-SERBP1chr146425149chr167891968875DRB1-0840GHTGIRRVGRRPDQQ1025
MAST2-SERBP1chr146425149chr167891968875DRB1-0840HTGIRRVGRRPDQQL1126
MAST2-SERBP1chr146425149chr167891968875DRB1-1103GHTGIRRVGRRPDQQ1025
MAST2-SERBP1chr146425149chr167891968875DRB1-1103HTGIRRVGRRPDQQL1126
MAST2-SERBP1chr146425149chr167891968875DRB1-1106GHTGIRRVGRRPDQQ1025
MAST2-SERBP1chr146425149chr167891968875DRB1-1106HTGIRRVGRRPDQQL1126
MAST2-SERBP1chr146425149chr167891968875DRB1-1121HSPLHGHTGIRRVGR520
MAST2-SERBP1chr146425149chr167891968875DRB1-1125GHTGIRRVGRRPDQQ1025
MAST2-SERBP1chr146425149chr167891968875DRB1-1141GHTGIRRVGRRPDQQ1025
MAST2-SERBP1chr146425149chr167891968875DRB1-1141HTGIRRVGRRPDQQL1126
MAST2-SERBP1chr146425149chr167891968875DRB1-1147GHTGIRRVGRRPDQQ1025
MAST2-SERBP1chr146425149chr167891968875DRB1-1147HTGIRRVGRRPDQQL1126
MAST2-SERBP1chr146425149chr167891968875DRB1-1154GHTGIRRVGRRPDQQ1025
MAST2-SERBP1chr146425149chr167891968875DRB1-1154HTGIRRVGRRPDQQL1126
MAST2-SERBP1chr146425149chr167891968875DRB1-1154HGHTGIRRVGRRPDQ924
MAST2-SERBP1chr146425149chr167891968875DRB1-1157GHTGIRRVGRRPDQQ1025
MAST2-SERBP1chr146425149chr167891968875DRB1-1157HTGIRRVGRRPDQQL1126
MAST2-SERBP1chr146425149chr167891968875DRB1-1159GHTGIRRVGRRPDQQ1025
MAST2-SERBP1chr146425149chr167891968875DRB1-1159HTGIRRVGRRPDQQL1126
MAST2-SERBP1chr146425149chr167891968875DRB1-1163GHTGIRRVGRRPDQQ1025
MAST2-SERBP1chr146425149chr167891968875DRB1-1163HTGIRRVGRRPDQQL1126
MAST2-SERBP1chr146425149chr167891968875DRB1-1176GHTGIRRVGRRPDQQ1025
MAST2-SERBP1chr146425149chr167891968875DRB1-1176HTGIRRVGRRPDQQL1126
MAST2-SERBP1chr146425149chr167891968875DRB1-1185GHTGIRRVGRRPDQQ1025
MAST2-SERBP1chr146425149chr167891968875DRB1-1185HTGIRRVGRRPDQQL1126
MAST2-SERBP1chr146425149chr167891968875DRB1-1303GHTGIRRVGRRPDQQ1025
MAST2-SERBP1chr146425149chr167891968875DRB1-1304GHTGIRRVGRRPDQQ1025
MAST2-SERBP1chr146425149chr167891968875DRB1-1304HTGIRRVGRRPDQQL1126
MAST2-SERBP1chr146425149chr167891968875DRB1-1304HGHTGIRRVGRRPDQ924
MAST2-SERBP1chr146425149chr167891968875DRB1-13101GHTGIRRVGRRPDQQ1025
MAST2-SERBP1chr146425149chr167891968875DRB1-13101HTGIRRVGRRPDQQL1126
MAST2-SERBP1chr146425149chr167891968875DRB1-1310GHTGIRRVGRRPDQQ1025
MAST2-SERBP1chr146425149chr167891968875DRB1-1310HTGIRRVGRRPDQQL1126
MAST2-SERBP1chr146425149chr167891968875DRB1-1312GHTGIRRVGRRPDQQ1025
MAST2-SERBP1chr146425149chr167891968875DRB1-1312HTGIRRVGRRPDQQL1126
MAST2-SERBP1chr146425149chr167891968875DRB1-1313GHTGIRRVGRRPDQQ1025
MAST2-SERBP1chr146425149chr167891968875DRB1-1313HTGIRRVGRRPDQQL1126
MAST2-SERBP1chr146425149chr167891968875DRB1-1318GHTGIRRVGRRPDQQ1025
MAST2-SERBP1chr146425149chr167891968875DRB1-1321GHTGIRRVGRRPDQQ1025
MAST2-SERBP1chr146425149chr167891968875DRB1-1321HTGIRRVGRRPDQQL1126
MAST2-SERBP1chr146425149chr167891968875DRB1-1321HGHTGIRRVGRRPDQ924
MAST2-SERBP1chr146425149chr167891968875DRB1-1324GHTGIRRVGRRPDQQ1025
MAST2-SERBP1chr146425149chr167891968875DRB1-1324HTGIRRVGRRPDQQL1126
MAST2-SERBP1chr146425149chr167891968875DRB1-1330GHTGIRRVGRRPDQQ1025
MAST2-SERBP1chr146425149chr167891968875DRB1-1330HTGIRRVGRRPDQQL1126
MAST2-SERBP1chr146425149chr167891968875DRB1-1332GHTGIRRVGRRPDQQ1025
MAST2-SERBP1chr146425149chr167891968875DRB1-1332HTGIRRVGRRPDQQL1126
MAST2-SERBP1chr146425149chr167891968875DRB1-1332HGHTGIRRVGRRPDQ924
MAST2-SERBP1chr146425149chr167891968875DRB1-1338GHTGIRRVGRRPDQQ1025
MAST2-SERBP1chr146425149chr167891968875DRB1-1338HTGIRRVGRRPDQQL1126
MAST2-SERBP1chr146425149chr167891968875DRB1-1338HGHTGIRRVGRRPDQ924
MAST2-SERBP1chr146425149chr167891968875DRB1-1343GHTGIRRVGRRPDQQ1025
MAST2-SERBP1chr146425149chr167891968875DRB1-1343HTGIRRVGRRPDQQL1126
MAST2-SERBP1chr146425149chr167891968875DRB1-1348GHTGIRRVGRRPDQQ1025
MAST2-SERBP1chr146425149chr167891968875DRB1-1348HTGIRRVGRRPDQQL1126
MAST2-SERBP1chr146425149chr167891968875DRB1-1348HGHTGIRRVGRRPDQ924
MAST2-SERBP1chr146425149chr167891968875DRB1-1349GHTGIRRVGRRPDQQ1025
MAST2-SERBP1chr146425149chr167891968875DRB1-1349HTGIRRVGRRPDQQL1126
MAST2-SERBP1chr146425149chr167891968875DRB1-1354GHTGIRRVGRRPDQQ1025
MAST2-SERBP1chr146425149chr167891968875DRB1-1354HTGIRRVGRRPDQQL1126
MAST2-SERBP1chr146425149chr167891968875DRB1-1355GHTGIRRVGRRPDQQ1025
MAST2-SERBP1chr146425149chr167891968875DRB1-1355HTGIRRVGRRPDQQL1126
MAST2-SERBP1chr146425149chr167891968875DRB1-1355HGHTGIRRVGRRPDQ924
MAST2-SERBP1chr146425149chr167891968875DRB1-1358GHTGIRRVGRRPDQQ1025
MAST2-SERBP1chr146425149chr167891968875DRB1-1358HTGIRRVGRRPDQQL1126
MAST2-SERBP1chr146425149chr167891968875DRB1-1358HGHTGIRRVGRRPDQ924
MAST2-SERBP1chr146425149chr167891968875DRB1-1361HSPLHGHTGIRRVGR520
MAST2-SERBP1chr146425149chr167891968875DRB1-1365GHTGIRRVGRRPDQQ1025
MAST2-SERBP1chr146425149chr167891968875DRB1-1365HTGIRRVGRRPDQQL1126
MAST2-SERBP1chr146425149chr167891968875DRB1-1365HGHTGIRRVGRRPDQ924
MAST2-SERBP1chr146425149chr167891968875DRB1-1366GHTGIRRVGRRPDQQ1025
MAST2-SERBP1chr146425149chr167891968875DRB1-1366HTGIRRVGRRPDQQL1126
MAST2-SERBP1chr146425149chr167891968875DRB1-1375GHTGIRRVGRRPDQQ1025
MAST2-SERBP1chr146425149chr167891968875DRB1-1375HTGIRRVGRRPDQQL1126
MAST2-SERBP1chr146425149chr167891968875DRB1-1375HGHTGIRRVGRRPDQ924
MAST2-SERBP1chr146425149chr167891968875DRB1-1376GHTGIRRVGRRPDQQ1025
MAST2-SERBP1chr146425149chr167891968875DRB1-1376HTGIRRVGRRPDQQL1126
MAST2-SERBP1chr146425149chr167891968875DRB1-1376HGHTGIRRVGRRPDQ924
MAST2-SERBP1chr146425149chr167891968875DRB1-1381GHTGIRRVGRRPDQQ1025
MAST2-SERBP1chr146425149chr167891968875DRB1-1381HTGIRRVGRRPDQQL1126
MAST2-SERBP1chr146425149chr167891968875DRB1-1381HGHTGIRRVGRRPDQ924
MAST2-SERBP1chr146425149chr167891968875DRB1-1388GHTGIRRVGRRPDQQ1025
MAST2-SERBP1chr146425149chr167891968875DRB1-1389GHTGIRRVGRRPDQQ1025
MAST2-SERBP1chr146425149chr167891968875DRB1-1389HTGIRRVGRRPDQQL1126
MAST2-SERBP1chr146425149chr167891968875DRB1-1389HGHTGIRRVGRRPDQ924
MAST2-SERBP1chr146425149chr167891968875DRB1-1390GHTGIRRVGRRPDQQ1025
MAST2-SERBP1chr146425149chr167891968875DRB1-1393GHTGIRRVGRRPDQQ1025
MAST2-SERBP1chr146425149chr167891968875DRB1-1393HTGIRRVGRRPDQQL1126
MAST2-SERBP1chr146425149chr167891968875DRB1-1393HGHTGIRRVGRRPDQ924
MAST2-SERBP1chr146425149chr167891968875DRB1-1394GHTGIRRVGRRPDQQ1025
MAST2-SERBP1chr146425149chr167891968875DRB1-1394HTGIRRVGRRPDQQL1126
MAST2-SERBP1chr146425149chr167891968875DRB1-1395GHTGIRRVGRRPDQQ1025
MAST2-SERBP1chr146425149chr167891968875DRB1-1416GHTGIRRVGRRPDQQ1025
MAST2-SERBP1chr146425149chr167891968875DRB1-1416HTGIRRVGRRPDQQL1126
MAST2-SERBP1chr146425149chr167891968875DRB1-1453GHTGIRRVGRRPDQQ1025
MAST2-SERBP1chr146425149chr167891968875DRB1-1453HTGIRRVGRRPDQQL1126
MAST2-SERBP1chr146425149chr167891968875DRB1-1463GHTGIRRVGRRPDQQ1025
MAST2-SERBP1chr146425149chr167891968875DRB1-1463HTGIRRVGRRPDQQL1126
MAST2-SERBP1chr146425149chr167891968875DRB1-1473GHTGIRRVGRRPDQQ1025
MAST2-SERBP1chr146425149chr167891968875DRB1-1473HTGIRRVGRRPDQQL1126
MAST2-SERBP1chr146425149chr167891968875DRB1-1473HGHTGIRRVGRRPDQ924
MAST2-SERBP1chr146425149chr167891968875DRB1-1474GHTGIRRVGRRPDQQ1025
MAST2-SERBP1chr146425149chr167891968875DRB1-1474HTGIRRVGRRPDQQL1126
MAST2-SERBP1chr146425149chr167891968875DRB1-1478GHTGIRRVGRRPDQQ1025
MAST2-SERBP1chr146425149chr167891968875DRB1-1478HTGIRRVGRRPDQQL1126
MAST2-SERBP1chr146425149chr167891968875DRB1-1478HGHTGIRRVGRRPDQ924
MAST2-SERBP1chr146425149chr167891968875DRB1-1485GHTGIRRVGRRPDQQ1025
MAST2-SERBP1chr146425149chr167891968875DRB1-1485HTGIRRVGRRPDQQL1126
MAST2-SERBP1chr146425149chr167891968875DRB5-0106HSPLHGHTGIRRVGR520
MAST2-SERBP1chr146425149chr167891968875DRB5-0106PHSPLHGHTGIRRVG419
MAST2-SERBP1chr146425149chr167891968875DRB5-0106SPLHGHTGIRRVGRR621
MAST2-SERBP1chr146425149chr167891968875DRB5-0106RPHSPLHGHTGIRRV318
MAST2-SERBP1chr146425149chr167891968875DRB5-0111HSPLHGHTGIRRVGR520
MAST2-SERBP1chr146425149chr167891968875DRB5-0111PHSPLHGHTGIRRVG419
MAST2-SERBP1chr146425149chr167891968875DRB5-0202HSPLHGHTGIRRVGR520
MAST2-SERBP1chr146425149chr167891968875DRB5-0202PHSPLHGHTGIRRVG419
MAST2-SERBP1chr146425149chr167891968875DRB5-0202SPLHGHTGIRRVGRR621
MAST2-SERBP1chr146425149chr167891968875DRB5-0203HSPLHGHTGIRRVGR520
MAST2-SERBP1chr146425149chr167891968875DRB5-0203PHSPLHGHTGIRRVG419
MAST2-SERBP1chr146425149chr167891968875DRB5-0204HSPLHGHTGIRRVGR520
MAST2-SERBP1chr146425149chr167891968875DRB5-0204PHSPLHGHTGIRRVG419
MAST2-SERBP1chr146425149chr167891968875DRB5-0205HSPLHGHTGIRRVGR520

Top

Fusion breakpoint peptide structures of MAST2-SERBP1

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
8885SPLHGHTGIRRVGRMAST2SERBP1chr146425149chr167891968875

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of MAST2-SERBP1

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN8885SPLHGHTGIRRVGR-7.9962-8.1096
HLA-B14:023BVN8885SPLHGHTGIRRVGR-5.70842-6.74372
HLA-B52:013W398885SPLHGHTGIRRVGR-6.83737-6.95077
HLA-B52:013W398885SPLHGHTGIRRVGR-4.4836-5.5189
HLA-A11:014UQ28885SPLHGHTGIRRVGR-10.0067-10.1201
HLA-A11:014UQ28885SPLHGHTGIRRVGR-9.03915-10.0745
HLA-A24:025HGA8885SPLHGHTGIRRVGR-6.56204-6.67544
HLA-A24:025HGA8885SPLHGHTGIRRVGR-5.42271-6.45801
HLA-B44:053DX88885SPLHGHTGIRRVGR-7.85648-8.89178
HLA-B44:053DX88885SPLHGHTGIRRVGR-5.3978-5.5112
HLA-A02:016TDR8885SPLHGHTGIRRVGR-3.37154-4.40684

Top

Vaccine Design for the FusionNeoAntigens of MAST2-SERBP1

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
MAST2-SERBP1chr146425149chr1678919681120HTGIRRVGRACACAGGAATAAGACGAGTTGGAAGAA
MAST2-SERBP1chr146425149chr167891968515HSPLHGHTGIACTCACCACTCCATGGCCACACAGGAATAA
MAST2-SERBP1chr146425149chr167891968615SPLHGHTGICACCACTCCATGGCCACACAGGAATAA
MAST2-SERBP1chr146425149chr167891968918HGHTGIRRVATGGCCACACAGGAATAAGACGAGTTG

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
MAST2-SERBP1chr146425149chr1678919681025GHTGIRRVGRRPDQQGCCACACAGGAATAAGACGAGTTGGAAGAAGACCTGATCAACAAC
MAST2-SERBP1chr146425149chr1678919681126HTGIRRVGRRPDQQLACACAGGAATAAGACGAGTTGGAAGAAGACCTGATCAACAACTTC
MAST2-SERBP1chr146425149chr167891968318RPHSPLHGHTGIRRVGGCCACACTCACCACTCCATGGCCACACAGGAATAAGACGAGTTG
MAST2-SERBP1chr146425149chr167891968419PHSPLHGHTGIRRVGCACACTCACCACTCCATGGCCACACAGGAATAAGACGAGTTGGAA
MAST2-SERBP1chr146425149chr167891968520HSPLHGHTGIRRVGRACTCACCACTCCATGGCCACACAGGAATAAGACGAGTTGGAAGAA
MAST2-SERBP1chr146425149chr167891968621SPLHGHTGIRRVGRRCACCACTCCATGGCCACACAGGAATAAGACGAGTTGGAAGAAGAC
MAST2-SERBP1chr146425149chr167891968924HGHTGIRRVGRRPDQATGGCCACACAGGAATAAGACGAGTTGGAAGAAGACCTGATCAAC

Top

Information of the samples that have these potential fusion neoantigens of MAST2-SERBP1

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
PAADMAST2-SERBP1chr146425149ENST00000361297chr167891968ENST00000361219TCGA-LB-A7SX

Top

Potential target of CAR-T therapy development for MAST2-SERBP1

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to MAST2-SERBP1

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to MAST2-SERBP1

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource